Critical care aspects of alcohol abuse

Southern Medical Journal

Volumn 98, Issue 3, 2005, Pages 372-381

  Al Sanouri, Ibrahim ^a   Dikin, Matthew ^a   Soubani, Ayman O ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Alcohol abuse; Critical care; Delirium tremens; Liver disease; Upper gastrointestinal bleeding; Wernicke encephalopathy; Withdrawal

Indexed keywords

ALCOHOL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CEFOTAXIME; CHLORDIAZEPOXIDE; CLINDAMYCIN; CLONIDINE; CORTICOSTEROID; DIAZEPAM; HALOPERIDOL; LORAZEPAM; MACROLIDE; METRONIDAZOLE; NEOMYCIN; NEUROLEPTIC AGENT; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAXIMIN; SCLEROSING AGENT; SEDATIVE AGENT; SULBACTAM; THIAMINE; TIMENTIN; TRANQUILIZER; UNINDEXED DRUG;

ACUTE HEMORRHAGIC PANCREATITIS; ADULT RESPIRATORY DISTRESS SYNDROME; ALCOHOL ABUSE; ALCOHOL WITHDRAWAL; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DELIRIUM TREMENS; DIAGNOSTIC PROCEDURE; GASTROINTESTINAL DISEASE; HALLUCINATION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERACTIVITY; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY DISEASE; MEDICAL LITERATURE; MEDLINE; METABOLIC DISORDER; MORTALITY; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; PATHOPHYSIOLOGY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; UPPER GASTROINTESTINAL BLEEDING; WERNICKE ENCEPHALOPATHY;

ALCOHOL WITHDRAWAL DELIRIUM; ALCOHOLISM; CARDIOVASCULAR DISEASES; CRITICAL CARE; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT; WERNICKE ENCEPHALOPATHY;

EID: 15044342998     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000154769.33508.20     Document Type: Review

References (112)

1. Lowenfels AB. Epidemiologic studies of alcohol-related disease in the 20th century. J Epidemiol Biostat 2000;5:61.
2. Grant FF. Alcohol consumption, alcohol abuse and alcohol dependence: the United States as an example. Addiction 1994;89:1357-1365.
3. National Institute on Alcohol Abuse and Alcohol Abuse. Eighth Special Report to the US Congress on Alcohol and Health. Rockville, MD, 1993, DHHS Publication No. ADM:281-91-0003.
4. Chagas Silva M, Gaunekar G, Patel V, et al. The prevalence and correlates of hazardous drinking in industrial workers: a study from Goa, India. Alcohol Alcohol 2003;38:79-83.
5. Baldwin WA, Rosenfeld BA, Breslow MJ, et al. Substance abuse-related admissions to adult intensive care. Chest 1993;103:21-25.
6. Hall W, Zador D. The alcohol withdrawal syndrome. Lancet 1997;349:1897-900.
7. Bartug B, Fullwood J. Delirium tremens in acute myocardial infarction. Heart Lung 1994;23:21-26.
8. Agartz I, Shoaf S, Rawlings RR, et al. CSF monoamine metabolites and MRI brain volumes in alcohol dependence. Psychiatry Res 2003;20;122:21-35.
9. Chiang WK, Goldfrank LR. Substance withdrawal. Emerg Med Clin North Am 1990;8:613-631.
10. Surawicz FG. Alcoholic hallucinosis: a missed diagnosis. Can J Psychiatry 1980;25:57-63.
11. Victor M, Adams RD. The effects of alcohol on nervous system. Proc Assoc Res Nerv Ment Dis 1953;32:526-532.
12. Victor M, Brausch C. The role of abstinence in the genesis of alcoholic epilepsy. Epilepsia 1967;8:1-20.
13. Thompson WL. Management of alcohol withdrawal syndromes. Arch Intern Med 1978;138:278-283.
14. Turner RC, Lichstein PR, Peden JG Jr, et al. Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment. J Gen Intern Med 1989;4:432-444.
15. Morris JC, Victor M. Alcohol withdrawal seizures. Emerg Med Clin North Am 1987;5:827-839.
16. Smith GS, Falk H. Unintentional injuries. Am J Prev Med 1987;3:143-146.
17. Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989;84:1353-1357.
18. Ortiz J, Fitzgerald LW, Charlton M, et al. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 1995;21:289-298.
19. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science 1997;278:58-63.
20. Klinker JF, Lichtenberg-Kraag B, Damm H, et al. Activation of pertussis toxin sensitive G-protein in membranes of SH-SY5Y human neuroblastoma cells and bovine transducin by ethanol. Neurosci Lett 1996;213:25-28.
21. Ewing JA. Detecting alcohol abuse: the CAGE Questionnaire. JAMA 1984;252:1905-1907.
22. Buchsbaum DG, Buchanan RG, Centor RM, et al. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med 1991;115:774-777.
23. Soderstrom CA, Dischinger PC, Smith GS, et al. Psychoactive substance dependence among trauma center patients. JAMA 1992;267:2756.
24. Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991; 37:2029.
25. Figlie NB, Benedito-Silva AA, Monteiro MG, et al. Biological markers of alcohol consumption in nondrinkers, drinkers, and alcohol-dependent Brazilian patients. Alcohol Clin Exp Res 2002;26:1062-1069.
26. Brown CG. The alcohol withdrawal syndrome. Ann Emerg Med 1982; 11:276-280.
27. Wax PM. Withdrawal syndromes, in Rippe JM, Irwin RS, Fink MP, et al (eds): Intensive Care Medicine. 3rd edition. Boston, Little, Brown & Company, 1996, pp 1718-1726.
28. Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta analysis and evidence based practice guideline. JAMA 1997; 278:144-151.
29. Ritson B, Chick J. Comparison of two benzodiazepines in the treatment of alcohol withdrawal: effects on symptoms and cognitive recovery. Drug Alcohol Depend 1986;18:329-334.
30. Kraus ML, Gottlieb LD, Horwitz RI, Anscher M. Randomized clinical trial of Atenolol in patients with alcohol withdrawal. N Engl J Med 1985;313:905-910.
31. Sellers EM, Zilm DH, Degani NC. Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. J Stud Alcohol 1977;38:2096-2108.
32. Liskow BI, Reed J. Atenolol for alcohol withdrawal. N Eng J Med 1986;314:782-784.
33. Cushman P Jr, Forbes R, Lerner W, et al. Alcohol withdrawal syndromes: clinical management with Lefoxidine. Alcohol Abuse 1985;9:1103-1108.
34. Bjorkqvist SE. Clonidine in alcoholic withdrawal. Act Psychiatr Scand 1975;52:256-263.
35. Adams F, Fernandez F, Anderson BS. Emergency pharmacotherapy of delirium in the critically ill cancer patient. Psychomatics 1986;27:33-38.
36. Bjorkqvist SE, Isohanni M, Makela R, et al. Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicenter double blind comparison with placebo. Acta Psychiatr Scand 1976;53:333-342.
37. Ballenger JC, Post RM. Kindling as a model for the alcohol withdrawal syndromes. Br J Psychiatry 1978;133:1-14.
38. Funderburk FR, Allen RP, Wagman AM. Residual effect of ethanol and chlordiazepoxide treatment for alcohol withdrawal. J Nerv Ment Dis 1978;166:195-203.
39. Crippen D, Ermakov S. Titrated treatment of delirium tremens using continuous Propofol infusion. St Francis J Med (on line). Available at www.sfhs.edujournalv.2_n.1clinicalclinical.htm. Accessed May 1999.
40. Singleton CK, Pekovich SR, McCool BA, et al. The thiamine-dependent hysteric behavior of human transketolase: implications for thiamine deficiency. J Nutr 1995;125:189-194.
41. Blass JP, Gibson GE. Abnormality of a thiamine enzyme in-patients with Wernicke-Korsakoff syndrome. N Engl J Med 1977;297:1367.
42. Fawcett S, Young GB, Holliday RL. Wernicke encephalopathy after gastric partitioning for morbid obesity. Can J Surg 1984;27:169.
43. Schenker S, Henderson GI, Hoyumpa AM Jr, et al. Hepatic and Wernicke encephalopathies: current concepts of pathogenesis. Am J Clin Nur 1980;22:2719.
44. Victor M, Adams RD, Collins TG. The Wernicke-Korsakoff syndrome: a clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser 1971;7:1-206.
45. Kearsly JH, Musso AF. Hypothermia and coma in the Wernicke-Korsakoff syndrome. Med J Aust 1980;2:504.
46. Torvik A, Lindboe CF, Rogde S. Brain lesion in alcoholics: a neuropathological study with clinical correlation. J Neuro Sci 1982;56:233.
47. Feinnman L, Lieber C. Modern nutrition, in Shils M (ed): Health and Disease. 9th edition. Philadelphia, Lea and Febiger, 2000, p 1538.
48. Basile AS, Hughes RD, Harrison PM, et al. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med 1991;325:473.
49. Sleisenger MH, Fordtran JS. Gastrointestinal and Liver Disease. Philadelphia, Saunders, 1998, ed 6, 1334-1354.
50. Victor M, Ropper AH. Adams and Victor's Principles of Neurology. New York, McGraw-Hill, 2000, ed 7, 1205-1211.
51. Amodio P, Marchetti P, Del Piccolo F, et al. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 1999; 110:1334-1344.
52. Parsons-Smith BG, Summerskill WHJ, Dawson AM, et al. The electroencephalogram in liver disease. Lancet 1957;2:867-871.
53. Lockwood AH. Hepatic Encephalopathy. Boston, Butterworth-Heineman, 1992, pp 65-72.
54. Simons F, Goldstein H, Boyle JD. A controlled trial of lactulose in hepatic encephalopathy. Gastroenterology 1970;59:827-832.
55. Conn HO, Floch MH. Effects of lactulose and lactobacillus acidophilous on the fecal flora. Am J Clin Nutr 1970;23:1588-1594.
56. Price JB, Sawoda M, Voorhees AB. Clinical significance of intraluminal pH in intestinal ammonia transport. Am J Surg 1970;119:595-598.
57. Atterbury CE, Maddery WC, Conn HO. Neomycin, sorbitol and lactulose in the treatment of acute portal systemic encephalopathy: a controlled double blind clinical trial. Am J Dig Dis 1978;23:398-406.
58. Puxeddu A, Quartini M, Massimetti A, et al. Rifaximin in the treatment of chronic hepatic encephalopathy. Curr Med Res Opin 1995;13:274-228.
59. Mathurin P, Mendenhall CL, Carithers RL Jr, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002;36:480-487.
60. Capps JA, Coleman GH. Influence of alcohol on prognosis of pneumonia in Cook County Hospital. JAMA 1923;80:750-752.
61. Saitz R, Ghali WA, Moskowitz MA. The impact of alcohol-related diagnoses on pneumonia outcomes. Arch Intern Med 1997;157:1446-1452.
62. Jong GM, Hsiue TR, Chen CR, et al. Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics. Chest 1995;107:214-217.
63. Lebowitz MD. Respiratory symptoms and diseases related to alcohol consumption. Am Rev Respir Dis 1981;123:16-19.
64. Krumpe PE, Cummiskey JM, Lillington GA. Alcohol and the respiratory tract. Med Clin North Am 1984;68:201-219.
65. Glassman AB, Bennett CE. Effects of ethyl alcohol on human peripheral lymphocytes. Arch Pathol Lab Med 1985;109:540-542.
66. Mili F, Fanders WD, Boring JR, et al. The associations of alcohol drinking and drinking cessation to measures of the immune system in middle aged med. Alcohol Clin Exp Res 1992;16:688-694.
67. Guarneri JJ, Laurenzi GA. Effect of alcohol on the mobilization of alveolar macrophages. J Lab Clin Med 1968;72:40-51.
68. Saitz R, Ghali WA, Moskowitz MA. The impact of alcohol-related diagnoses on pneumonia outcomes. Arch Intern Med 1997;157:1446-1452.
69. Moss M, Bucher B, Moore FA, et al. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 1996;275:50-54.
70. Balla AK, Doi EM, Wunder PR, et al. Human polymorphonuclear leukocyte (PMN) priming and activation by acute ethanol intoxication. Adv Exp Med Biol 1993;335:165-168.
71. Laine L. Upper gastrointestinal hemorrhage. West J Med 1991;155:274.
72. Laine L, Weinstein WM. Subepithelial hemorrhage and erosions of human stomach. Dig Dis Sci 1988;33:490.
73. Larine L, Weinstein WM. Histology of alcoholic hemorrhage "gastritis": a prospective evaluation. Gastroenterology 1988;94:1254.
74. Valencia Parracen J. Alcoholic gastritis. Clin Gastroenterol 1981;10:289-399.
75. Graham D, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800.
76. Imperiale TF, Teran JC, McCullough AJ. A meta analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage. Gastroenterology 1995;109:1289-1294.
77. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for the treatment of esophageal variceal bleeding: a meta analysis. Ann Intern Med 1995;123:280-287.
78. Lo GH, Lai KH, Cheng JS, et al. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 1997;25:1101-1104.
79. Jalan R, John TG, Redhead DN, et al. A comparative study of emergency transjugular intrahepatic portal systemic stent shunt and esophageal transection in the management of uncontrolled varices hemorrhage. Am J Gastroenterol 1995;90:1932-1937.
80. Deschenes M, Villenceuve JP. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol 1999;94:2193-2197.
81. Goulis J, Armonos A, Patch D, et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998;27:1207-1212.
82. Beranard B, Grange JD, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infection in cirrhotic patients with GI bleeding: a meta analysis. Hepatology 1999;29:1655-1661.
83. Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med 1999;340:1412-1417.
84. Pratt DS, Epstein SK. Recent advances in critical care gastroenterology. Am J Respir Crit Care Med 2000;161:1417-1421.
85. Guelrud M, Mendoza S, Rossiter G, et al. Effect of local institution of alcohol on sphincter of Oddi motor activity: combined ERCP and manometry study. Gastrointest Endosc 1999;37:428.
86. Gronroos JM, Aho HJ, Nevalainen JJ. Cholinergic hypothesis of alcoholic pancreatitis. Dig Dis Sci 1992;10:38.
87. Renner IG, Rinderknecht H, Valenznela JE, et al. Studies in pure pancreatitis secretions in chronic alcoholic subjects without pancreatic insufficiency. Scand J Gastroenterol 1980;15:241.
88. Reynaert MS, Dugernier TH, Kestens PJ. Current therapeutic strategies in severe acute pancreatitis. Intensive Care Med 1990;16:352.
89. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994;330:1198-2076.
90. Kalfarentzos F, Kehagias J, Mead N, et al. Enteral nutrition is superior to parental nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 1997;84:166-169.
91. Sainio VE, Kemppainen P, Puolakkainen M, et al. Early antibiotic treatment in acute necrotizing pancreatitis. Lancet 1995;346:663-667.
92. Ho HS, Frey CF. The role of antibiotic prophylaxis in severe acute pancreatitis. Arch Surg 1997;132:487-492.
93. Pederzoli P, Bassi C, Vesentinin S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993; 176:480-483.
94. Rau B, Pralle U, Mayer JM, et al. Role of ultrasonographically guided fine needle aspiration cytology in the diagnosis of infected pancreatic necrosis. Br J Surg 1998;85:179-184.
95. Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med 1999;340:1412-1417.
96. Mier J, Leon EL, Castillo A, et al. Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg 1997;173:71-75.
97. Baron TH, Thaggard WG, Morgan DE, et al. Endoscopic therapy of organized pancreatic necrosis. Gastroenterology 1996;111:755-764.
98. Turner RC, Oakley NW, Nabarro JDN. Changes in plasma insulin during ethanol-induced hypoglycemia. Metabolism 1973;22:111.
99. Newell GC. Cirrhotic glomerulonephritis: incidence, microbiology, clinical features. Am J Kidney Dis 1987;9:183-190.
100. Fauchier L, Babuty D, Poret P, et al. Comparison of long term outcome of alcoholic and idiopathic dilated cardiomyopathy. Eur Heart J 2000; 21:306-314.
101. McKenna CJ, Codd MB, McCann HA, et al. Alcohol consumption in idiopathic dilated cardiomyopathy: a case control study. Am Heart J 1998;135:833-837.
102. De Keulenaer GGW, Brutsaert DL. Dilated cardiomyopathies: pathophysiology concepts and mechanisms of dysfunction. J Card Surg 1999;14:64-74.
103. Dancy M, Bland JM, Leech G, et al. Preclinical left ventricular abnormalities in alcoholic are independent of nutritional status, cirrhosis and cigarette smoking. Lancet 1985;1:1122-1125.
104. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circulation 1998;82:1111-1129.
105. Cartwright MM, Smith SM. Increased cell death and reduced neural crest cell numbers in ethanol-exposed embryos: partial basis for the fatal alcohol syndrome phenotype. Alcohol Clin Exp Res 1995;19:378-386.
106. Segel LD, Rendig SV, Mason DT. Alcohol- induced hemodynamic and CA+2 flux dysfunctions are reversible. J Mol Cell Cardiol 1981;13:443-455.
107. Segel LD, Rendig SV, Choquet Y, et al. Effects of chronic graded ethanol consumption on the metabolism function of the real heart. Cardiovasc Res 1975;9:649-663.
108. Sarma JS, Ikeda S, Fischer R, et al. Biochemical and contractile properties of heart muscle after prolonged alcohol administration. J Mol Cell Cardiol 1976;8:951-972.
109. Preedy VR, Peters TJ. The acute and chronic effects of ethanol on cardiac muscle protein synthesis in the rat in vivo. Alcohol 1990;71:97-102.
110. Preedy VR, Patel VB, Why HJF, et al. Alcohol and the heart: biochemical alternations. Cardiovasc Res 1996;31:139-147.
111. Piano MR. Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 2002;121:1638-1650.
112. Lowenstein SR, Gabow PA, Cramer J, et al. The role of alcohol in new-onset atrial fibrillation. Arch Intern Med 1983;143:1882-1885.